Ulland Investment Advisors LLC Reduces Holdings in Viemed Healthcare, Inc. (NASDAQ:VMD)

Ulland Investment Advisors LLC reduced its holdings in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) by 20.4% in the 1st quarter, HoldingsChannel.com reports. The fund owned 15,560 shares of the company’s stock after selling 4,000 shares during the period. Ulland Investment Advisors LLC’s holdings in Viemed Healthcare were worth $113,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the business. Ameriprise Financial Inc. acquired a new stake in shares of Viemed Healthcare during the 4th quarter worth about $340,000. Nuveen Asset Management LLC boosted its stake in shares of Viemed Healthcare by 22.1% during the 4th quarter. Nuveen Asset Management LLC now owns 162,272 shares of the company’s stock worth $1,301,000 after purchasing an additional 29,320 shares during the last quarter. Arrowstreet Capital Limited Partnership acquired a new stake in shares of Viemed Healthcare during the 4th quarter worth about $1,549,000. EntryPoint Capital LLC acquired a new stake in shares of Viemed Healthcare during the 4th quarter worth about $92,000. Finally, Rhumbline Advisers boosted its stake in shares of Viemed Healthcare by 15.5% during the 4th quarter. Rhumbline Advisers now owns 46,836 shares of the company’s stock worth $376,000 after purchasing an additional 6,275 shares during the last quarter. 74.24% of the stock is currently owned by hedge funds and other institutional investors.

Viemed Healthcare Price Performance

Viemed Healthcare stock opened at $6.75 on Thursday. Viemed Healthcare, Inc. has a 12-month low of $6.14 and a 12-month high of $9.81. The stock has a market capitalization of $266.79 million, a P/E ratio of 25.00 and a beta of 1.38. The firm’s 50-day moving average is $6.75 and its two-hundred day moving average is $7.57. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19.

Viemed Healthcare (NASDAQ:VMD) last released its earnings results on Wednesday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.06. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%. The business had revenue of $59.10 million for the quarter, compared to analysts’ expectations of $60.60 million.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.